Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lycke

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
European Journal of Neurology|February 6, 2016
Minocycline added to subcutaneous interferon β-1a in multiple sclerosis: randomized RECYCLINE studyP S Sørensen, F Sellebjerg, J Lycke, et al.
Clinical Journal of Sport Medicine : Official Journal of the Canadian Academy of Sport Medicine|February 8, 2020
Distribution of Head Acceleration Events Varies by Position and Play Type in North American FootballTaylor A Lee, Roy J Lycke, Patrick J Lee, et al.
Multiple Sclerosis and Related Disorders|October 15, 2022
Effectiveness of first generation disease-modifying therapy to prevent conversion to secondary progressive multiple sclerosisH Tedeholm, F Piehl, J Lycke, et al.
Annals of Clinical and Translational Neurology|April 13, 2026
Dimethyl Fumarate, But Not Rituximab, Reduces Serum GFAP Levels and PIRMA in Relapsing-Remitting MSF Shawket, J Lycke, J Salzer, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 6, 2012
Time to secondary progression in patients with multiple sclerosis who were treated with first generation immunomodulating drugsH Tedeholm, J Lycke, B Skoog, et al.
International Journal of Molecular Sciences|May 21, 2015
Imaging of small animal peripheral artery disease models: recent advancements and translational potentialJenny B Lin, Evan H Phillips, Ti'Air E Riggins, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 21, 2009
Reduced cerebrospinal fluid BACE1 activity in multiple sclerosisN Mattsson, M Axelsson, S Haghighi, et al.
Neuroimage. Clinical|October 21, 2019
Every hit matters: White matter diffusivity changes in high school football athletes are correlated with repetitive head acceleration event exposureIkbeom Jang, Il Yong Chun, Jared R Brosch, et al.
Acta Neurologica Scandinavica|August 26, 2016
Guidelines for the use of magnetic resonance imaging in diagnosing and monitoring the treatment of multiple sclerosis: recommendations of the Swedish Multiple Sclerosis Association and the Swedish Neuroradiological SocietyM Vågberg, M Axelsson, R Birgander, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 15, 2015
Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre studyJ Kuhle, G Disanto, R Dobson, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
European Journal of Neurology|February 6, 2016
Minocycline added to subcutaneous interferon β-1a in multiple sclerosis: randomized RECYCLINE studyP S Sørensen, F Sellebjerg, J Lycke, et al.
Clinical Journal of Sport Medicine : Official Journal of the Canadian Academy of Sport Medicine|February 8, 2020
Distribution of Head Acceleration Events Varies by Position and Play Type in North American FootballTaylor A Lee, Roy J Lycke, Patrick J Lee, et al.
Multiple Sclerosis and Related Disorders|October 15, 2022
Effectiveness of first generation disease-modifying therapy to prevent conversion to secondary progressive multiple sclerosisH Tedeholm, F Piehl, J Lycke, et al.
Annals of Clinical and Translational Neurology|April 13, 2026
Dimethyl Fumarate, But Not Rituximab, Reduces Serum GFAP Levels and PIRMA in Relapsing-Remitting MSF Shawket, J Lycke, J Salzer, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 6, 2012
Time to secondary progression in patients with multiple sclerosis who were treated with first generation immunomodulating drugsH Tedeholm, J Lycke, B Skoog, et al.
International Journal of Molecular Sciences|May 21, 2015
Imaging of small animal peripheral artery disease models: recent advancements and translational potentialJenny B Lin, Evan H Phillips, Ti'Air E Riggins, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 21, 2009
Reduced cerebrospinal fluid BACE1 activity in multiple sclerosisN Mattsson, M Axelsson, S Haghighi, et al.
Neuroimage. Clinical|October 21, 2019
Every hit matters: White matter diffusivity changes in high school football athletes are correlated with repetitive head acceleration event exposureIkbeom Jang, Il Yong Chun, Jared R Brosch, et al.
Acta Neurologica Scandinavica|August 26, 2016
Guidelines for the use of magnetic resonance imaging in diagnosing and monitoring the treatment of multiple sclerosis: recommendations of the Swedish Multiple Sclerosis Association and the Swedish Neuroradiological SocietyM Vågberg, M Axelsson, R Birgander, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 15, 2015
Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre studyJ Kuhle, G Disanto, R Dobson, et al.
Pageof 5